Effects of sub-MIC concentrations of antibiotics on growth of and toxin production by Clostridium difficile

被引:47
作者
Drummond, LJ [1 ]
Smith, DGE [1 ]
Poxton, IR [1 ]
机构
[1] Univ Edinburgh, Sch Med, Ctr Infect Dis, Edinburgh, Midlothian, Scotland
关键词
D O I
10.1099/jmm.0.05387-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Effects on growth and toxin A production of sub-MIC concentrations of six different antibiotics were investigated in three strains of Clostridium difficile: reference strain NCTC 11223, a fully sequenced strain (630) and a locally endemic isolate (strain 338a). The antibiotics chosen for investigation were the agents used to treat C. difficile-associated disease (CDAD), i.e. vancomycin and metroniclazole, and four antibiotics that are commonly involved in precipitating CDAD (amoxycillin, clindamycin, cefoxitin and ceftriaxone). Strains were cultured in sublethal concentrations of antibiotics (1/2, 1/4 and 1/8 MIC) over 104 h and growth and toxin A production were measured three times a day. Effects varied between strain and antibiotic. The most common effect on growth of the strains was to increase the initial lag period by approximately 4 h, compared with antibiotic-free controls; however, strain NCTC 11223, which has high-level clindamycin resistance (greater than or equal to 512 mug ml(-1)), showed no lag whatsoever in comparison with the controls when grown in this antibiotic. The most common effect on production of toxin A was in the onset of toxin elaboration. Normally, toxins began to appear at low levels in the early stationary phase, before accumulating to high levels by the start of decline. In the presence of sub-MIC antibiotics, this onset appeared before that of the antibiotic-free controls. This effect was seen with metroniclazole, amoxycillin and clindamycin, rarely with vancomycin and never with cefoxitin. These results suggest a very complex, strain-dependent relationship between the effects of growth and toxin production.
引用
收藏
页码:1033 / 1038
页数:6
相关论文
共 21 条
[1]  
[Anonymous], NCCLS PUBL
[2]   EFFECTS OF ANTIBIOTICS AND OTHER DRUGS ON TOXIN PRODUCTION IN CLOSTRIDIUM-DIFFICILE INVITRO AND INVIVO [J].
BARC, MC ;
DEPITRE, C ;
CORTHIER, G ;
COLLIGNON, A ;
SU, WJ ;
BOURLIOUX, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (06) :1332-1335
[3]  
BROWN R, 1996, MACKIE MCCARTNEY PRA, P507
[4]   Regulated transcription of Clostridium difficile toxin genes [J].
Dupuy, B ;
Sonenshein, AL .
MOLECULAR MICROBIOLOGY, 1998, 27 (01) :107-120
[5]  
Farrell RJ, 2000, CURR TOP MICROBIOL, V250, P109
[6]   Genomic analysis of the erythromycin resistance element Tn5398 from Clostridium difficile [J].
Farrow, KA ;
Lyras, D ;
Rood, JI .
MICROBIOLOGY-SGM, 2001, 147 :2717-2728
[7]   Analysis of expression of GroEL (Hsp60) of Clostridium difficile in response to stress [J].
Hennequin, C ;
Collignon, A ;
Karjalainen, T .
MICROBIAL PATHOGENESIS, 2001, 31 (05) :255-260
[8]  
HONDA T, 1983, LANCET, V1, P655
[9]  
Ikeda D, 1998, ZBL BAKT-INT J MED M, V287, P375
[10]   Suppression of toxin production in Clostridium difficile VPI 10463 by amino acids [J].
Karlsson, S ;
Burman, LG ;
Åkerlund, T .
MICROBIOLOGY-UK, 1999, 145 :1683-1693